Angiotensin Ii type 1 receptor blocking agents in regression of cardiac hypertrophy--how and why?
Paul, B.; Goyal, R.K.
Indian Heart Journal 52(1): 19-22
2000
ISSN/ISBN: 0019-4832 PMID: 10820928 Document Number: 517887
Document emailed within 1 workday
Related Documents
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72Zhang, J-qun.; Sun, H-lei.; Ma, Y-xin.; Wang, D-wen. 2006: Effects of RNA interference targeting angiotensin 1a receptor on the blood pressure and cardiac hypertrophy of rats with 2K1C hypertension Zhonghua Yi Xue Za Zhi 86(16): 1138-1143
González-Juanatey, J.R.; Vallés Belsué, F. 2000: Angiotensin Ii type 1 receptor antagonists in cardiac insufficiency Medicina Clinica 114(Suppl 1): 43-45
Tachikawa, H.; Kodama, M.; Hui, L.; Yoshida, T.; Hayashi, M.; Abe, S.; Kashimura, T.; Kato, K.; Hanawa, H.; Watanabe, K.; Nakazawa, M.; Aizawa, Y. 2003: Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis Journal of Cardiovascular Pharmacology 41(Suppl): S105-S110
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Swynghedauw, B.; Chevalier, B. 1995: Biological characteristics of the myocardium during the regression of cardiac hypertrophy due to mechanical overload Journal of Heart Valve Disease 4(Suppl 2): S154-S159
Sims, J.M.; Patzer, B.; Kumudavalli-Reddy, M.; Martin, A.F.; Rabinowitz, M.; Zak, R. 1976: The pathways of protein synthesis and degradation in normal heart and during development and regression of cardiac hypertrophy Recent Advances in Studies on Cardiac Structure and Metabolism 12: 19-28
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Benetos, A.; Gautier, S.; Ricard, S.; Topouchian, J.; Asmar, R.; Poirier, O.; Larosa, E.; Guize, L.; Safar, M.; Soubrier, F.; Cambien, F. 1996: Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients Circulation 94(4): 698-703
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Fu, M.; Zhang, J.; Xu, S.; Pang, Y.; Liu, N.; Tang, C. 2001: Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats Chinese Medical Sciences Journal 16(1): 1-4
Breithaupt-Grögler, K.; Malerczyk, C.; Belz, G.G.; Butzer, R.; Herrmann, V.; Stass, H.; Wensing, G. 1997: Pharmacodynamic and pharmacokinetic properties of an angiotensin Ii receptor antagonist--characterization by use of Schild regression technique in man International Journal of Clinical Pharmacology and Therapeutics 35(10): 434-441
Aoyama, N. 2007: Effect of combination therapy with angiotensin Ii type i receptor and aldosterone receptor blockers in heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 145-149
Gong, J.-j.; Lu, Z.-q.; Cao, J.-l.; Xu, C.-s.; Wang, H.-j.; Jin, X.-q. 2012: Overexpression of angiotensin-converting enzyme 2 inhibits angiotensin Ii type 1 receptor expression and signal transducer and activator of transcription 3 phosphorylation in cultured smooth muscle cells Zhonghua Xin Xue Guan Bing Za Zhi 40(7): 607-613
Quock, R.M.; Lum, M.H.; Small, S.F. 1979: Interaction of N,N-dimethyltryptamine with central neuroaminergic receptor blocking agents Proceedings of the Western Pharmacology Society 22: 217-218
Ros, F.E.; Dake, C.L.; Innemee, H.C.; van Zwieten, P.A. 1981: Beta-receptor blocking agents and glaucoma; timolol in eye drops Nederlands Tijdschrift Voor Geneeskunde 125(11): 422-425
Stienstra, R.; de Leeuw, P.W. 1980: Anesthesia in patients under treatment with beta-receptor blocking agents Nederlands Tijdschrift Voor Geneeskunde 124(44): 1878-1881
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Gáti, T.; Keszler, P.; Zelles, T.; Pucsok, J. 1971: Effect of adrenergic receptor blocking agents on the development of experimental ulcer in the rat Acta Physiologica Academiae Scientiarum Hungaricae 40(3): 393-396